X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 01, 2019

European Medicines Agency's (EMA) Strategy on Engaging with Regulatory Science

Where science and technology are evolving quickly, a good networking structure is needed to keep pace of advancements. This is especially relevant for regulatory agencies in the pharmaceutical field. EMA recognizes this and addresses it with the strategic plan: <em>Regulatory Science to 2025</em> &ndash; focused on quality, safety and efficacy of both human and veterinary medicines. The draft of this plan, which was created by the Member States and the European Commission, and comprised input from two workshops with stakeholders, was published in December 2018 for a six-month public consultation.
Bettine Boltres

Bettine Boltres, Ph.D.

Principal, Scientific Affairs, Packaging & Delivery Systems

Previous Posts
CPhI China Tradeshow

June 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

Particle Analysis

June 11, 2019

Particulate Challenges

Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

A nurse extracting a medication from a vial into a syringe

June 04, 2019

Are You Ready? Compliance with New USP Chapters <381>, <382>, <1381> and <1382>

Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Laboratory

Introducing Integrated Solutions

May 02, 2019

FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Load more